Cargando…
Liraglutide inhibits the progression of prediabetes in rats by reducing Raf-1 kinase inhibitor protein
BACKGROUND: The cleavage product of Raf-1 kinase inhibitor protein (RKIP), hippocampal cholinergic neurostimulating peptide (HCNP) is involved in the promotion of insulin secretion. Studies have shown that liraglutide can inhibit the progression of prediabetes. This study aims to investigate whether...
Autores principales: | Gao, Fei, Wu, Dingying, Guo, Lingling, Wang, Lixue, Hao, Min, Li, Ling, Ni, Dongmei, Hao, Haojie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350642/ https://www.ncbi.nlm.nih.gov/pubmed/34430598 http://dx.doi.org/10.21037/atm-21-3094 |
Ejemplares similares
-
Liraglutide: another reason to target prediabetes?
por: Murphy, Conor F., et al.
Publicado: (2017) -
RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis
por: Zebisch, Armin, et al.
Publicado: (2019) -
Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors
por: Marusiak, Anna A., et al.
Publicado: (2014) -
Benefits of Liraglutide Treatment in Overweight and Obese Older Individuals With Prediabetes
por: Kim, Sun H., et al.
Publicado: (2013) -
Structure and RAF family kinase isoform selectivity of type II RAF inhibitors tovorafenib and naporafenib
por: Tkacik, Emre, et al.
Publicado: (2023)